Cre8MDI is pleased to announce that it has been honored to receive a Milestone Achievement Grant (MAP) from the Massachusetts Life Science Center (MLSC) in the amount of $200,000. The MLSC Board approved the first round of Milestone Achievement Program on Tuesday, May 26th.
“The MLSC’s Milestone Achievement Program provides an excellent opportunity for early-stage companies to grow and develop within Massachusetts’ fast-growing innovation economy,” said Governor Charlie Baker.
This new grant program was created to address the need of early-stage life science companies to reach critical value. The MLSC awarded more than $2million in funds to Massachusetts companies in order to support their work toward completion or fulfillment of a defined milestone.
It was a very competitive grant program with many life science companies vying for the funds. The MSLC determined that Cre8MDI met all the criteria and had a clear milestone driven proposal. The Board of Directors, Peer Reviewers, SAB, and Center staff were involved with reviewing the company’s business plan, science and future potential.
“We are pleased to be supporting Cre8MDI with this grant funding to help the company achieve a milestone in their product development” said MLSC Vice President for Communications & Marketing Angus McQuilken. “Cre8MDI is part of a vibrant and growing life sciences community in the Merrimack Valley that is creating jobs, while bringing technologies to market that will improve patient care and human health.”
David Cassidy, President of Cre8MDI stated, “This grant will fund our next stage of development. We are pleased with the validation this grant provides our company as we move forward to predict cardiovascular disease with ease.”
Official MLSC Press Release: http://www.masslifesciences.com/news/announcements/